{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:19:05Z","timestamp":1760300345517},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T00:00:00Z","timestamp":1585353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>In 2012, the US Preventive Services Task Force decreased the recommended frequency of cervical cytology screening to once every 3 years and recommended against testing women younger than 21 years regardless of sexual history. We evaluated the impact of this in 21 to 29-year-old women at a tertiary care academic medical center in 2011 and 2017.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We retrospectively analyzed Papanicolaou test results at two time points in 21- to 29-year-old women.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There was a decrease in the number of high-grade lesions in 21- to 25-year-old women (odds ratio [OR], 0.36) from 2011 to 2017. Within the 26- to 29-year-old patient group, there was a trend toward a higher percentage of high-grade squamous intraepithelial lesion (HSIL) in 2017 compared to 2011 on cytology, which did not reach statistical significance (OR, 1.46). However, follow-up histologic specimens showed a higher percentage of HSIL in 2017 compared to 2011 in this age group (OR, 2.16).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our findings suggest that the cervical cancer screening guidelines introduced in 2012 have not had a detrimental impact on the outcomes of cervical cancer screening for 21- to 25-year-old women. However, we need to continue monitoring the effects of decreased screening in 26- to 29-year-old women.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqaa012","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T20:09:02Z","timestamp":1579637342000},"page":"734-742","source":"Crossref","is-referenced-by-count":6,"title":["Impact of the Current US Preventive Services Task Force Recommendations for Cervical Cancer Screening in Young Women 21 to 29 Years Old"],"prefix":"10.1093","volume":"153","author":[{"given":"C Paul","family":"Morris","sequence":"first","affiliation":[{"name":"Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD"},{"name":"National Institute of Allergy and Infectious Disease, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayanan","family":"Chowsilpa","sequence":"first","affiliation":[{"name":"Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD"},{"name":"Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Mustafa","sequence":"first","affiliation":[{"name":"Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Chan","sequence":"first","affiliation":[{"name":"Department of Oncology, The Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Miller","sequence":"first","affiliation":[{"name":"Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Maleki","sequence":"first","affiliation":[{"name":"Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika F","family":"Rodriguez","sequence":"first","affiliation":[{"name":"Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,3,28]]},"reference":[{"key":"2020050514075796700_CIT0001","author":"International Agency for Research on Cancer"},{"key":"2020050514075796700_CIT0002","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1023\/A:1018435522475","article-title":"International incidence rates of invasive cervical cancer after introduction of cytological screening","volume":"8","author":"Gustafsson","year":"1997","journal-title":"Cancer Causes Control."},{"key":"2020050514075796700_CIT0003","doi-asserted-by":"crossref","first-page":"b2968","DOI":"10.1136\/bmj.b2968","article-title":"Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data","volume":"339","author":"Sasieni","year":"2009","journal-title":"BMJ."},{"key":"2020050514075796700_CIT0004","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ijc.23922","article-title":"How many cervical cancers are prevented by treatment of screen-detected disease in young women?","volume":"124","author":"Sasieni","year":"2009","journal-title":"Int J Cancer."},{"key":"2020050514075796700_CIT0005","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med."},{"key":"2020050514075796700_CIT0006","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am J Clin Pathol."},{"key":"2020050514075796700_CIT0007","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"key":"2020050514075796700_CIT0008","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/AOG.0000000000000632","article-title":"Increased cervical cancer risk associated with screening at longer intervals","volume":"125","author":"Kinney","year":"2015","journal-title":"Obstet Gynecol."},{"key":"2020050514075796700_CIT0009","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-11074-5","volume-title":"The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria and Explanatory Notes","author":"Nayar","year":"2015","edition":"3"},{"key":"2020050514075796700_CIT0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1309\/AJCPM9X5RCZYEQJQ","article-title":"Low-grade squamous intraepithelial lesion\/cannot exclude high-grade squamous intraepithelial lesion (LSIL-H) is a unique category of cytologic abnormality associated with distinctive HPV and histopathologic CIN 2+ detection rates","volume":"141","author":"Barron","year":"2014","journal-title":"Am J Clin Pathol."},{"key":"2020050514075796700_CIT0011","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/cncr.11721","article-title":"The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion","volume":"99","author":"Nasser","year":"2003","journal-title":"Cancer."},{"key":"2020050514075796700_CIT0012","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol."},{"key":"2020050514075796700_CIT0013","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2303.2011.00955.x","article-title":"Type 1 and type 2 cervical carcinomas: some cervical cancers are more difficult to prevent with screening","volume":"23","author":"Austin","year":"2012","journal-title":"Cytopathology."},{"key":"2020050514075796700_CIT0014","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.acap.2017.09.014","article-title":"Ten years of human papillomavirus vaccination in the United States","volume":"18","author":"Markowitz","year":"2018","journal-title":"Acad Pediatr."},{"key":"2020050514075796700_CIT0015","author":"Merck & Co Ltd."},{"key":"2020050514075796700_CIT0016","doi-asserted-by":"crossref","first-page":"429.e1","DOI":"10.1016\/j.ajog.2017.12.209","article-title":"Patterns and correlates of cervical cancer screening initiation in a large integrated health care system","volume":"218","author":"Becerra-Culqui","year":"2018","journal-title":"Am J Obstet Gynecol."},{"key":"2020050514075796700_CIT0017","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2016.11.031","article-title":"Trends in cervical cancer incidence in younger US women from 2000 to 2013","volume":"144","author":"Beachler","year":"2017","journal-title":"Gynecol Oncol"},{"key":"2020050514075796700_CIT0018","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/cid\/ciy707","article-title":"Trends in high-grade cervical lesions and cervical cancer screening in five states, 2008-2015","volume":"68","author":"Gargano","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020050514075796700_CIT0019","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s10552-014-0392-4","article-title":"Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program","volume":"25","author":"Baldur-Felskov","year":"2014","journal-title":"Cancer Causes Control."},{"key":"2020050514075796700_CIT0020","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/jech-2017-209113","article-title":"The impact of bivalent HPV vaccine on cervical intraepithelial neoplasia by deprivation in Scotland: reducing the gap","volume":"71","author":"Cameron","year":"2017","journal-title":"J Epidemiol Community Health."},{"key":"2020050514075796700_CIT0021","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/1055-9965.EPI-18-0885","article-title":"Trends in human papillomavirus vaccine types 16 and 18 in cervical precancers, 2008-2014","volume":"28","author":"McClung","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2020050514075796700_CIT0022","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"2020050514075796700_CIT0023","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1158\/1055-9965.EPI-10-0131","article-title":"Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy","volume":"19","author":"Carozzi","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"2020050514075796700_CIT0024","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","article-title":"Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer","volume":"14","author":"Clifford","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"2020050514075796700_CIT0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pvr.2018.10.010","article-title":"Changes in human papillomavirus genotypes associated with cervical intraepithelial neoplasia grade 2 lesions in a cohort of young women (2013-2016)","volume":"6","author":"Innes","year":"2018","journal-title":"Papillomavirus Res"},{"key":"2020050514075796700_CIT0026","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.27713","article-title":"Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe","volume":"132","author":"Tjalma","year":"2013","journal-title":"Int J Cancer."},{"key":"2020050514075796700_CIT0027","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1158\/0008-5472.CAN-08-4192","article-title":"Detection of precancerous cervical lesions is differential by human papillomavirus type","volume":"69","author":"Safaeian","year":"2009","journal-title":"Cancer Res."},{"key":"2020050514075796700_CIT0028","doi-asserted-by":"crossref","first-page":"918","DOI":"10.15585\/mmwr.mm6733a2","article-title":"Trends in human papillomavirus-associated cancers - United States, 1999-2015","volume":"67","author":"Van Dyne","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/153\/6\/734\/33172350\/aqaa012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/153\/6\/734\/33172350\/aqaa012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T18:59:30Z","timestamp":1588705170000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/153\/6\/734\/5812988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,28]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,3,28]]},"published-print":{"date-parts":[[2020,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqaa012","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2020,3,28]]}}}